FDA issues alert about ‘possible accuracy concerns’ with rapid coronavirus test used by White House

Published May 15, 2020 11:47am ET



The Food and Drug Administration issued an alert about “possible accuracy problems” with the rapid coronavirus test used by the White House after studies questioned its accuracy.

A recent New York University study, which has not yet been peer-reviewed, found that Abbott’s ID NOW missed at least one-third of positive cases detected by a different test. The number of false negatives increased when using the currently recommended dry nasal swabs.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.